This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Today's Small-Cap Winners and Losers

Genta's (GNTA) shares were rising on news the Food and Drug Administration has accepted the biotech company's new drug application for the Genasense injection.

The company wants to use Genasense, which has had a rocky history, along with fludarabine and cyclophosphamide for treating patients with relapsed or refractory chronic lymphocytic leukemia. Shares of Genta gained 8 cents, or 2.9%, to $2.87.

Genaera (GENR) saw its shares fall 5% after the company posted a fourth-quarter loss of $7.8 million, or 11 cents a share, on revenue of $42,000. The biopharmaceutical company lost $4.9 million, or 8 cents a share, with revenue of $29,000 in the year-ago period. Shares were losing 9 cents to $1.65.

Harris & Harris (TINY) was climbing after Punk Ziegel raised its price target on the venture capital company's stock to $19 from $16.50. Shares of Harris & Harris were up 87 cents, or 6.6%, to $14.09.

MSGI Security Solutions (MSGI) advanced 3.3% after the company said it received contracts for security products and services with two foreign governments. The exact nature of the contracts in Europe and the broader Middle East are confidential.

However, MSGI said the contracts establish long-term relationships that will result in at least $2 million in revenue over the next two years. Separately, MSGI has formally started operations in the Caribbean. Shares of MSGI were up 12 cents to $3.77.

Shares of Carrington Laboratories (CARN) were skyrocketing after the company said its DelSite Biotechnologies unit selected Invitrogen's (IVGN) PD-Direct services to develop a process for a cell-based avian H5 influenza antigen that will be used in a nasal vaccine.

DelSite is developing a nasal powder vaccine for pandemic avian influenza that combines its GelVac vaccine delivery system with an avian H5 influenza whole virion antigen. Carrington, a biopharmaceutical company, was jumping $1.79, or 39.5%, to $6.34.

FX Energy (FXEN) shares were plunging following word from the company that the Drozdowice-1 well in western Poland will be plugged and abandoned. A drillstem test of the target reservoir yielded no observable hydrocarbons, FX said. The stock was dropping $1.03, or 18.6%, to $4.50.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs